Curosurf 240 mg/3 ml Suspension Recall by Chiesi SAS

The French National Agency for Medicines and Health Products Safety (ANSM) has reported a precautionary recall of Lot 1211845 (expiring 07/2026) of Curosurf 240 mg/3 ml suspension for endotracheobronchial instillation, manufactured by Chiesi SAS. This recall is a direct measure taken with the ANSM following a resolved deviation identified in the production site's environmental monitoring. While no pharmacovigilance cases related to this quality defect have been reported, the recall is being conducted directly with the affected hospital facilities.

Healthcare providers in France who may have received or administered this specific lot of Curosurf should be aware of the recall and follow the instructions provided by Chiesi SAS and the ANSM. Although the deviation is resolved and no adverse events have been reported, entities should ensure proper handling and return of the affected product. No specific compliance deadline or penalty information is provided, as this is a direct recall to healthcare facilities.